UC College of Medicine forms Center for Addiction Research
October 1, 2020
The UC College of Medicine has established the Center for Addiction Research to expand the university’s scope as a national leader in addiction science.
October 1, 2020
The UC College of Medicine has established the Center for Addiction Research to expand the university’s scope as a national leader in addiction science.
April 15, 2022
University of Cincinnati researchers Jeffrey Mills and Jeffrey Strawn have collaborated on a new research study showing socioeconomic factors affect outcomes for patients being treated for depression even when receiving equal access to care.
September 29, 2021
UC experts explain how public health guidelines like mask requirements affects anxiety levels among groups of people, including children, first responders and other front line workers.
May 10, 2022
Research from the University of Cincinnati shows daily blueberry supplementation for certain middle-aged populations may lower the chances of developing late-life dementia.
December 5, 2022
University of Cincinnati researchers have published a new study examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
February 6, 2023
A $1.25 million gift from PESI will allow researchers at the UC College of Medicine to explore therapies used for posttraumatic stress disorder (PTSD).
February 8, 2023
Steven Kniffley Jr., PsyD, has been named senior associate dean for diversity, equity and inclusion (DEI) at the UC College of Medicine
June 27, 2022
The University of Cincinnati is currently enrolling patients for clinical trials testing new medications to treat post-traumatic stress disorder.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
December 20, 2023
The University of Cincinnati's Francisco Romo-Nava published research in the journal Molecular Psychiatry that found noninvasive spinal cord stimulation is safe and has therapeutic potential to treat depression.